Medical software developer Brainomix has been awarded £900k ($1.4m) to develop the software version of an already used stroke assessment system by the UK’s Technology Strategy Board.
The funding will assist Brainomix in developing its software, which helps physicians in identifying which patients are most likely to benefit from stroke treatment. From when a stroke occurs, there is only a four and half hour window in which a patient can receive treatment. The faster a doctor can assess and treat a patient, the more potential they will have for a fuller life following a stroke.
Michalis Papadakis, co-founder of Brainomix, said: “After incorporating less than 6 months ago, this funding is a great vote of confidence in us and the medical importance of our stroke e-ASPECTS software.”
The startup launched earlier this year after incubation at Oxford University’s tech transfer unit Isis Innovation.
